Outside the Box: FDA needs to loosen up on CBD but clamp down on quality claims

Outside the Box: FDA needs to loosen up on CBD but clamp down on quality claims

Enhance consumer protections by establishing product quality-assurance standards, not by restricting access to CBD.

Read More…

Leave a Reply

Your email address will not be published. Required fields are marked *